#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	272	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1151	12.6	0	.	p	.	0	K29T	NONSYN	85	87	AAG	337	339	ACG	16;16;13	A;C;G	16;16;13	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	144	Chlamydophila_psittaci_16S	1507	129	91.47	Chlamydophila_psittaci_16S.l6.c30.ctg.1	170	10.7	0	.	n	.	0	T879G	SNP	879	879	T	57	57	G	5	G	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	144	Chlamydophila_psittaci_16S	1507	129	91.47	Chlamydophila_psittaci_16S.l6.c30.ctg.1	170	10.7	0	.	n	.	0	G880A	SNP	880	880	G	58	58	A	4	A	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	144	Chlamydophila_psittaci_16S	1507	129	91.47	Chlamydophila_psittaci_16S.l6.c30.ctg.1	170	10.7	0	.	n	.	0	A888G	SNP	888	888	A	66	66	G	6	G	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	144	Chlamydophila_psittaci_16S	1507	129	91.47	Chlamydophila_psittaci_16S.l6.c30.ctg.1	170	10.7	0	.	n	.	0	C897G	SNP	897	897	C	75	75	G	6	G	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	144	Chlamydophila_psittaci_16S	1507	129	91.47	Chlamydophila_psittaci_16S.l6.c30.ctg.1	170	10.7	0	.	n	.	0	T898C	SNP	898	898	T	76	76	C	6	C	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	144	Chlamydophila_psittaci_16S	1507	129	91.47	Chlamydophila_psittaci_16S.l6.c30.ctg.1	170	10.7	0	.	n	.	0	G906T	SNP	906	906	G	84	84	T	7	T	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	144	Chlamydophila_psittaci_16S	1507	129	91.47	Chlamydophila_psittaci_16S.l6.c30.ctg.1	170	10.7	0	.	n	.	0	G908A	SNP	908	908	G	86	86	A	7	A	7	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	144	Chlamydophila_psittaci_16S	1507	129	91.47	Chlamydophila_psittaci_16S.l6.c30.ctg.1	170	10.7	0	.	n	.	0	A918T	SNP	918	918	A	96	96	T	9	T	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	144	Chlamydophila_psittaci_16S	1507	129	91.47	Chlamydophila_psittaci_16S.l6.c30.ctg.1	170	10.7	0	.	n	.	0	A943G	SNP	943	943	A	121	121	G	22	G	22	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1014	Escherichia_coli_EF_Tu	1230	1210	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1414	34.6	1	SNP	p	R234F	1	.	.	700	702	TTC	904	906	TTC	35;36;36	T;T;C	35;36;36	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1014	Escherichia_coli_EF_Tu	1230	1210	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1414	34.6	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1204	1206	CGT	36;36;35	C;G;T	36;36;35	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1014	Escherichia_coli_EF_Tu	1230	1210	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1414	34.6	0	HET	.	.	.	C261T	.	261	261	C	465	465	C	43	C,T	24,19	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1014	Escherichia_coli_EF_Tu	1230	1210	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1414	34.6	0	HET	.	.	.	C144T	.	144	144	C	348	348	C	27	C,T	13,13	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1014	Escherichia_coli_EF_Tu	1230	71	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	269	4.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	16	392	Escherichia_coli_mutant_1	1359	1140	99.82	Escherichia_coli_mutant_1.l6.c30.ctg.2	1315	12.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	532	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1602	17.4	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1205	1207	GAA	20;20;21	G;A;A	20;20;21	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	170	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	686	11.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	65	G	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	66	T	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	77	G	76	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	69	C	69	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	62	C	62	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	64	T	63	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	64	C	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	47	C	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	49	A	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	50	A	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	49	A	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	50	T	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	49	C	48	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	54	C	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	55	A	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	49	G	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	50	C	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	57	T	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	73	G	73	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	77	G	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	78	T	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	80	T	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	79	G	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	62	C	62	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	61	A	61	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	37	C	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	34	C	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	11	A	11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	11	A	11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	10	G	10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	7	C	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	39	T	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	43	G	43	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	35	T	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	81	C	81	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	1512	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	713	54.4	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	59	C,T	34,9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	422	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1352	16.2	0	.	p	.	0	H2R	NONSYN	4	6	CAT	261	263	CGT	21;22;21	C;G;T	20;21;21	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	422	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1352	16.2	0	.	p	.	0	V30I	NONSYN	88	90	GTC	345	347	ATC	15;14;13	A;T;C	14;14;13	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	422	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1352	16.2	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1104	1106	GGC	15;16;18	G;G;C	14;15;18	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	576	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1978	15.5	0	.	p	.	0	R8S	NONSYN	22	24	AGA	176	178	AGC	4;4;4	A;G;C	4;4;4	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	576	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1978	15.5	0	.	p	.	0	I142L	NONSYN	424	426	ATA	578	580	CTA	9;9;9	C;T;A	9;9;9	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	576	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1978	15.5	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1097	1099	CAA	22;22;24	C;A;A	22;22;24	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	576	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1978	15.5	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1196	1198	GGT	21;21;21	G;G;T	21;20;21	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	576	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1978	15.5	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1766	1768	GTT	8;8;8	G;T;T	8;8;8	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	262	PmrE	1167	378	99.47	PmrE.l6.c4.ctg.1	548	11.2	0	.	p	.	0	A125E	NONSYN	373	375	GCA	543	545	GAA	6;6;5	G;A;A	6;6;5	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	262	PmrE	1167	756	95.63	PmrE.l6.c4.ctg.2	817	9.3	0	.	p	.	0	M185T	NONSYN	553	555	ATG	143	145	ACC	4;4;5	A;C;C	4;4;5	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	262	PmrE	1167	756	95.63	PmrE.l6.c4.ctg.2	817	9.3	0	.	p	.	0	S225T	NONSYN	673	675	TCC	263	265	ACT	11;11;11	A;C;T	11;11;11	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	262	PmrE	1167	756	95.63	PmrE.l6.c4.ctg.2	817	9.3	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	653	655	ATC	4;5;5	A;T;C	4;4;4	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	326	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1317	12.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	326	aad-	789	789	100.0	aad-.l6.c4.ctg.1	1230	14.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1042	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3438	16.0	0	.	p	.	0	T85I	NONSYN	253	255	ACC	369	371	ATC	10;10;12	A;T;C	10;10;12	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1042	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3438	16.0	0	.	p	.	0	V416I	NONSYN	1246	1248	GTC	1362	1364	ATC	15;16;16	A;T;C	15;16;16	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1042	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3438	16.0	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2082	2084	AAG	12;12;13	A;A;G	12;12;13	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	446	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1202	18.3	0	.	p	.	0	A22V	NONSYN	64	66	GCC	84	86	GTC	7;7;7	G;T;C	7;7;7	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	446	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1202	18.3	0	.	p	.	0	S269C	NONSYN	805	807	AGC	825	827	TGC	22;22;22	T;G;C	22;22;22	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	922	acrF	3105	2598	98.04	acrF.l6.c17.ctg.1	3075	15.9	0	.	p	.	0	S46trunc	TRUNC	136	136	T	371	371	T	5	T	5	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	922	acrF	3105	2598	98.04	acrF.l6.c17.ctg.1	3075	15.9	0	.	p	.	0	G148D	NONSYN	442	444	GGC	677	679	GAC	18;18;19	G;A;C	18;18;19	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	922	acrF	3105	2598	98.04	acrF.l6.c17.ctg.1	3075	15.9	0	.	p	.	0	F240L	NONSYN	718	720	TTT	953	955	TTA	18;17;17	T;T;A	18;17;17	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	922	acrF	3105	2598	98.04	acrF.l6.c17.ctg.1	3075	15.9	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1136	1138	AAT	17;17;18	A;A;T	16;17;18	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	922	acrF	3105	2598	98.04	acrF.l6.c17.ctg.1	3075	15.9	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1923	1923	T	25	T	24	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	244	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1076	12.1	1	SNP	p	R45C	0	.	.	133	135	CGC	346	348	CGC	21;21;21	C;G;C	21;21;21	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	218	acrS	663	663	98.64	acrS.l15.c4.ctg.1	922	12.3	0	.	p	.	0	L34F	NONSYN	100	102	CTC	204	206	TTC	14;13;13	T;T;C	14;13;13	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	218	acrS	663	663	98.64	acrS.l15.c4.ctg.1	922	12.3	0	.	p	.	0	E122G	NONSYN	364	366	GAG	468	470	GGG	11;11;12	G;G;G	11;11;12	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	290	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1130	13.6	0	.	p	.	0	V136L	NONSYN	406	408	GTT	578	580	CTT	21;22;22	C;T;T	21;22;22	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	944	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3052	16.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2062	2064	GCA	22;23;22	G;C;A	22;22;22	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	944	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3052	16.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2323	2325	ACC	20;20;20	A;C;C	19;20;20	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	944	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3052	16.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2632	2634	GCC	18;18;17	G;C;C	18;17;17	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	531	488	arnA_1	1983	1873	98.34	arnA_1.l15.c4.ctg.1	2015	12.4	0	.	p	.	0	D77E	NONSYN	229	231	GAT	120	122	GAG	4;4;5	G;A;G	4;4;5	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	531	488	arnA_1	1983	1873	98.34	arnA_1.l15.c4.ctg.1	2015	12.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	156	158	TGC	8;8;8	T;G;C	8;8;8	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	531	488	arnA_1	1983	1873	98.34	arnA_1.l15.c4.ctg.1	2015	12.4	0	.	p	.	0	I150V	NONSYN	448	450	ATT	339	341	GTT	7;7;7	G;T;T	7;7;7	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	531	488	arnA_1	1983	1873	98.34	arnA_1.l15.c4.ctg.1	2015	12.4	0	.	p	.	0	R200H	NONSYN	598	600	CGC	489	491	CAC	8;8;8	C;A;C	8;8;8	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	531	488	arnA_1	1983	1873	98.34	arnA_1.l15.c4.ctg.1	2015	12.4	0	.	p	.	0	T295M	NONSYN	883	885	ACG	774	776	ATG	18;18;19	A;T;G	18;18;19	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	531	488	arnA_1	1983	1873	98.34	arnA_1.l15.c4.ctg.1	2015	12.4	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1770	1772	CGC	11;11;12	C;G;C	11;11;12	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	238	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1045	11.5	0	.	p	.	0	S221T	NONSYN	661	663	AGC	841	843	ACC	6;6;6	A;C;C	5;6;6	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	238	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1045	11.5	0	.	p	.	0	P225S	NONSYN	673	675	CCG	853	855	TCG	8;8;8	T;C;G	8;8;8	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	192	baeR	723	723	97.79	baeR.l6.c30.ctg.1	946	10.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	332	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1676	10.5	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1299	1301	AAA	2;2;2	A;A;A	2;2;2	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	332	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1676	10.5	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1311	1313	GAG	2;2;3	G;A;G	2;2;2	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	332	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1676	10.5	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1317	1319	CAC	3;3;3	C;A;C	3;3;2	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	332	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1676	10.5	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1371	1373	GAG	4;4;4	G;A;G	4;4;4	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	454	cpxA	1374	1374	98.91	cpxA.l6.c4.ctg.1	1616	14.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	316	cpxR	699	699	99.43	cpxR.l15.c17.ctg.1	1144	14.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	274	cysB	975	975	99.28	cysB.l15.c30.ctg.1	1322	11.0	0	.	p	.	0	A146T	NONSYN	436	438	GCT	586	588	ACT	11;12;13	A;C;T	11;12;13	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	152	dfrA1_1	474	474	100.0	dfrA1_1.l15.c4.ctg.1	741	10.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	376	emrA	1173	1173	98.29	emrA.l6.c4.ctg.1	1592	12.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	847	849	GTC	11;11;10	G;T;C	11;11;10	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	526	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	1990	14.0	0	.	p	.	0	E197K	NONSYN	589	591	GAA	864	866	AAA	13;15;15	A;A;A	13;15;15	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	424	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1594	14.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	822	824	AGC	5;5;5	A;G;C	5;5;5	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	20	emrE_1	333	91	96.7	emrE_1.l15.c4.ctg.1	91	5.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	254	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1493	9.1	0	.	p	.	0	K176R	NONSYN	526	528	AAG	737	739	AGG	7;7;7	A;G;G	7;7;7	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	254	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1493	9.1	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1127	1129	GAC	9;9;9	G;A;C	9;9;8	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	206	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1030	10.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	454	emrY	1539	1539	99.81	emrY.l15.c17.ctg.1	1972	11.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	146	evgA	615	615	99.19	evgA.l15.c4.ctg.1	884	8.3	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	268	270	CTG	11;12;12	C;T;G	11;12;12	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	2481	97.86	evgS.l15.c30.ctg.1	2731	12.5	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	184	186	AAA	3;3;3	A;A;A	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	2481	97.86	evgS.l15.c30.ctg.1	2731	12.5	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	919	921	CAT	11;11;11	C;A;T	10;11;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	2481	97.86	evgS.l15.c30.ctg.1	2731	12.5	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	973	975	CAT	9;10;10	C;A;T	9;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	2481	97.86	evgS.l15.c30.ctg.1	2731	12.5	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	991	993	AGA	4;4;4	A;G;A	4;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	2481	97.86	evgS.l15.c30.ctg.1	2731	12.5	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1006	1008	AAT	5;5;6	A;A;T	5;5;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	2481	97.86	evgS.l15.c30.ctg.1	2731	12.5	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1153	1155	TCC	8;8;8	T;C;C	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	2481	97.86	evgS.l15.c30.ctg.1	2731	12.5	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1318	1320	ATT	4;4;4	A;T;T	4;4;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	2481	97.86	evgS.l15.c30.ctg.1	2731	12.5	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1339	1341	GAT	5;5;5	G;A;T	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	2481	97.86	evgS.l15.c30.ctg.1	2731	12.5	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1453	1455	GTT	10;9;9	G;T;T	10;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	2481	97.86	evgS.l15.c30.ctg.1	2731	12.5	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1738	1740	CAC	14;14;13	C;A;C	14;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	510	96.08	evgS.l15.c30.ctg.2	510	5.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	11	13	CAG	1;1;3	C;A;G	1;1;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	510	96.08	evgS.l15.c30.ctg.2	510	5.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	149	151	GTT	6;6;5	G;T;T	6;6;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	510	96.08	evgS.l15.c30.ctg.2	510	5.6	0	.	p	.	0	N303D	NONSYN	907	909	AAT	305	307	GAT	6;6;6	G;A;T	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	510	96.08	evgS.l15.c30.ctg.2	510	5.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	473	475	AAT	3;3;3	A;A;T	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	510	96.08	evgS.l15.c30.ctg.2	510	5.6	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	494	496	TTA	2;2;1	T;T;A	2;2;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	490	96.94	evgS.l15.c30.ctg.3	490	10.2	0	.	p	.	0	L42V	NONSYN	124	126	CTA	7	9	GTA	3;3;3	G;T;A	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	490	96.94	evgS.l15.c30.ctg.3	490	10.2	0	.	p	.	0	A93T	NONSYN	277	279	GCG	160	162	ACG	6;5;4	A;C;G	6;5;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	490	96.94	evgS.l15.c30.ctg.3	490	10.2	0	.	p	.	0	A114E	NONSYN	340	342	GCA	223	225	GAA	16;15;14	G;A;A	16;15;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	490	96.94	evgS.l15.c30.ctg.3	490	10.2	0	.	p	.	0	T127A	NONSYN	379	381	ACT	262	264	GCT	7;7;7	G;C;T	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	490	96.94	evgS.l15.c30.ctg.3	490	10.2	0	.	p	.	0	N133D	NONSYN	397	399	AAT	280	282	GAT	9;9;9	G;A;T	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	490	96.94	evgS.l15.c30.ctg.3	490	10.2	0	.	p	.	0	P162S	NONSYN	484	486	CCA	367	369	TCA	5;5;5	T;C;A	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	830	evgS	3594	112	100.0	evgS.l15.c30.ctg.4	163	10.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	280	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1231	12.0	1	SNP	p	P64L	0	.	.	190	192	CCA	370	372	CCA	22;22;22	C;C;A	21;21;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	280	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1231	12.0	1	SNP	p	P64H	0	.	.	190	192	CCA	370	372	CCA	22;22;22	C;C;A	21;21;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	280	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1231	12.0	1	SNP	p	P64S	0	.	.	190	192	CCA	370	372	CCA	22;22;22	C;C;A	21;21;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	280	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1231	12.0	1	SNP	p	P64A	0	.	.	190	192	CCA	370	372	CCA	22;22;22	C;C;A	21;21;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	280	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1231	12.0	1	SNP	p	P64R	0	.	.	190	192	CCA	370	372	CCA	22;22;22	C;C;A	21;21;21	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	170	gadE	528	528	100.0	gadE.l15.c4.ctg.1	976	9.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	203	93.1	gadW.l6.c4.ctg.1	203	4.4	0	.	p	.	0	I88M	NONSYN	262	264	ATA	8	10	ATG	3;3;3	A;T;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	203	93.1	gadW.l6.c4.ctg.1	203	4.4	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	11	13	CCG	3;3;3	C;C;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	203	93.1	gadW.l6.c4.ctg.1	203	4.4	0	.	p	.	0	D100E	NONSYN	298	300	GAC	44	46	GAA	2;2;2	G;A;A	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	203	93.1	gadW.l6.c4.ctg.1	203	4.4	0	.	p	.	0	P101S	NONSYN	301	303	CCC	47	49	TCC	2;2;2	T;C;C	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	203	93.1	gadW.l6.c4.ctg.1	203	4.4	0	.	p	.	0	R102G	NONSYN	304	306	CGG	50	52	GGG	2;2;2	G;G;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	203	93.1	gadW.l6.c4.ctg.1	203	4.4	0	.	p	.	0	K110N	NONSYN	328	330	AAA	74	76	AAT	1;1;1	A;A;T	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	120	97.5	gadW.l6.c4.ctg.2	123	8.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	200	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1005	9.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	315	317	TTA	9;9;7	T;T;A	9;9;7	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	200	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1005	9.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	393	395	ATT	9;9;9	A;T;T	9;9;9	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	200	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1005	9.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	894	896	GGA	8;8;8	G;G;A	8;8;8	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	200	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1005	9.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	900	902	CCG	9;8;8	C;C;G	9;8;8	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	986	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3140	16.7	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2294	2296	GAA	14;14;15	G;A;A	14;14;14	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	986	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3140	16.7	1	SNP	p	S83L	0	.	.	247	249	TCG	509	511	TCG	22;22;20	T;C;G	22;21;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	986	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3140	16.7	1	SNP	p	S83W	0	.	.	247	249	TCG	509	511	TCG	22;22;20	T;C;G	22;21;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	986	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3140	16.7	1	SNP	p	S83I	0	.	.	247	249	TCG	509	511	TCG	22;22;20	T;C;G	22;21;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	986	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3140	16.7	1	SNP	p	D87G	0	.	.	259	261	GAC	521	523	GAC	20;20;20	G;A;C	19;18;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	986	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3140	16.7	1	SNP	p	D87H	0	.	.	259	261	GAC	521	523	GAC	20;20;20	G;A;C	19;18;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	986	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3140	16.7	1	SNP	p	D87Y	0	.	.	259	261	GAC	521	523	GAC	20;20;20	G;A;C	19;18;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	986	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3140	16.7	1	SNP	p	D87V	0	.	.	259	261	GAC	521	523	GAC	20;20;20	G;A;C	19;18;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	986	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3140	16.7	1	SNP	p	D87N	0	.	.	259	261	GAC	521	523	GAC	20;20;20	G;A;C	19;18;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	824	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2877	15.2	1	SNP	p	R136C	0	.	.	406	408	CGC	706	708	CGC	19;19;18	C;G;C	19;19;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	824	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2877	15.2	1	SNP	p	R136E	0	.	.	406	408	CGC	706	708	CGC	19;19;18	C;G;C	19;19;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	824	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2877	15.2	1	SNP	p	R136L	0	.	.	406	408	CGC	706	708	CGC	19;19;18	C;G;C	19;19;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	824	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2877	15.2	1	SNP	p	R136I	0	.	.	406	408	CGC	706	708	CGC	19;19;18	C;G;C	19;19;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	824	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2877	15.2	1	SNP	p	R136G	0	.	.	406	408	CGC	706	708	CGC	19;19;18	C;G;C	19;19;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	824	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2877	15.2	1	SNP	p	R136H	0	.	.	406	408	CGC	706	708	CGC	19;19;18	C;G;C	19;19;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	824	gyrB_1	2415	2415	99.05	gyrB_1.l6.c4.ctg.1	2877	15.2	1	SNP	p	R136S	0	.	.	406	408	CGC	706	708	CGC	19;19;18	C;G;C	19;19;18	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	218	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1044	10.9	0	.	p	.	0	A72P	NONSYN	214	216	GCG	451	453	CCG	8;8;8	C;C;G	7;8;8	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	218	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1044	10.9	0	.	p	.	0	T123A	NONSYN	367	369	ACC	604	606	GCC	9;9;10	G;C;C	8;9;10	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	376	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1336	14.8	0	.	p	.	0	P9S	NONSYN	25	27	CCA	126	128	TCA	4;5;5	T;C;A	4;5;5	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	128	marA	384	384	99.74	marA.l6.c30.ctg.1	750	8.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	349	351	AGC	5;4;4	A;G;C	5;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	V45E	0	.	.	133	135	GTG	175	177	GTG	7;6;6	G;T;G	7;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	I49S	0	.	.	145	147	ATC	187	189	ATC	7;6;6	A;T;C	7;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	A70T	0	.	.	208	210	GCA	250	252	GCA	4;4;4	G;C;A	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	R73C	0	.	.	217	219	CGT	259	261	CGT	7;7;7	C;G;T	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	R73S	0	.	.	217	219	CGT	259	261	CGT	7;7;7	C;G;T	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	R77C	0	.	.	229	231	CGC	271	273	CGC	7;7;7	C;G;C	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	R77L	0	.	.	229	231	CGC	271	273	CGC	7;7;7	C;G;C	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	L78M	0	.	.	232	234	CTG	274	276	CTG	7;7;7	C;T;G	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	R94H	0	.	.	280	282	CGC	322	324	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	R94S	0	.	.	280	282	CGC	322	324	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	64	marR	435	408	97.79	marR.l6.c30.ctg.1	450	5.6	1	SNP	p	V96E	0	.	.	286	288	GTA	328	330	GTA	4;4;4	G;T;A	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	292	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1320	10.6	0	.	p	.	0	V12trunc	TRUNC	34	34	G	99	99	G	8	G	8	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	292	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1320	10.6	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	156	158	CAG	8;7;7	C;A;G	7;7;7	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	292	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1320	10.6	0	.	p	.	0	T83I	NONSYN	247	249	ACC	306	308	ATC	7;7;7	A;T;C	7;7;7	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	292	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1320	10.6	0	.	p	.	0	I99M	NONSYN	295	297	ATA	354	356	ATG	7;7;9	A;T;G	7;7;9	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	292	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1320	10.6	0	.	p	.	0	A130T	NONSYN	388	390	GCC	447	449	ACC	12;12;12	A;C;C	12;12;12	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	292	mdtA	1248	1248	97.36	mdtA.l15.c30.ctg.1	1320	10.6	0	.	p	.	0	P257T	NONSYN	769	771	CCG	828	830	ACG	12;12;14	A;C;G	12;12;14	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	982	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3380	15.3	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1906	1908	ACC	25;25;25	A;C;C	25;24;24	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	982	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3380	15.3	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2299	2301	CAA	5;5;7	C;A;A	5;5;7	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	982	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3380	15.3	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2467	2469	ATT	11;11;12	A;T;T	11;11;12	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	982	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3380	15.3	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2551	2553	GTT	16;16;16	G;T;T	16;16;16	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	982	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3380	15.3	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2659	2661	GAG	15;15;15	G;A;G	15;15;15	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	982	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3380	15.3	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2887	2889	ATG	5;5;5	A;T;G	5;5;5	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	982	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3380	15.3	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3022	3024	GAT	12;12;12	G;A;T	12;11;11	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	872	mdtC	3078	2914	98.76	mdtC.l15.c4.ctg.1	3116	14.5	0	.	p	.	0	I46M	NONSYN	136	138	ATC	338	340	ATG	13;12;11	A;T;G	13;12;11	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	872	mdtC	3078	2914	98.76	mdtC.l15.c4.ctg.1	3116	14.5	0	.	p	.	0	V208I	NONSYN	622	624	GTC	824	826	ATC	8;7;8	A;T;C	8;7;8	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	872	mdtC	3078	167	96.41	mdtC.l15.c4.ctg.2	187	5.5	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	27	29	CAC	4;4;4	C;A;C	3;4;4	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	515	872	mdtC	3078	167	96.41	mdtC.l15.c4.ctg.2	187	5.5	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	30	32	CTC	4;4;4	C;T;C	4;4;4	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	406	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1673	12.4	0	.	p	.	0	D3E	NONSYN	7	9	GAT	225	227	GAA	6;6;6	G;A;A	6;6;6	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	406	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1673	12.4	0	.	p	.	0	T226A	NONSYN	676	678	ACG	894	896	GCG	9;9;9	G;C;G	9;9;9	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	406	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1673	12.4	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1236	1238	ATC	10;9;9	A;T;C	9;9;9	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	406	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1673	12.4	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1539	1541	TTT	19;19;18	T;T;T	19;19;18	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	448	mdtE	1158	1158	99.31	mdtE.l6.c30.ctg.1	1589	15.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1104	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3635	16.2	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1132	1134	ACC	6;6;6	A;C;C	6;6;6	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1104	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3635	16.2	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2374	2376	GAC	29;29;29	G;A;C	28;29;28	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	376	mdtG	1227	1047	99.33	mdtG.l15.c17.ctg.1	1555	10.8	0	.	p	.	0	V200I	NONSYN	598	600	GTC	663	665	ATC	6;7;6	A;T;C	6;7;6	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	376	mdtG	1227	174	99.43	mdtG.l15.c17.ctg.2	202	8.6	0	.	p	.	0	E5G	NONSYN	13	15	GAA	5	7	GGA	2;3;4	G;G;A	2;3;4	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	358	mdtH	1209	1205	98.17	mdtH.l15.c30.ctg.1	1254	14.1	0	.	p	.	0	G134C	NONSYN	400	402	GGT	396	398	TGT	10;10;10	T;G;T	10;10;10	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	358	mdtH	1209	1205	98.17	mdtH.l15.c30.ctg.1	1254	14.1	0	.	p	.	0	S324L	NONSYN	970	972	TCG	966	968	TTG	11;13;13	T;T;G	11;12;13	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	358	mdtH	1209	1205	98.17	mdtH.l15.c30.ctg.1	1254	14.1	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1176	1178	ACG	3;3;3	A;C;G	3;3;3	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	450	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1688	14.2	0	.	p	.	0	A185S	NONSYN	553	555	GCC	845	847	TCC	9;9;11	T;C;C	9;9;11	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	296	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1435	10.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	515	517	ATT	12;11;12	A;T;T	12;11;12	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	654	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2313	15.0	0	.	p	.	0	V11M	NONSYN	31	33	GTG	99	101	ATG	9;8;8	A;T;G	9;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	654	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2313	15.0	0	.	p	.	0	T33I	NONSYN	97	99	ACC	165	167	ATC	8;8;8	A;T;C	8;8;8	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	654	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2313	15.0	0	.	p	.	0	C116R	NONSYN	346	348	TGC	414	416	CGC	16;16;16	C;G;C	16;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	654	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2313	15.0	0	.	p	.	0	N238S	NONSYN	712	714	AAC	780	782	AGC	15;15;15	A;G;C	14;15;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	654	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2313	15.0	0	.	p	.	0	M305V	NONSYN	913	915	ATG	981	983	GTG	6;6;6	G;T;G	6;6;6	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	654	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2313	15.0	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1044	1046	AAC	10;10;10	A;A;C	7;7;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	654	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2313	15.0	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1089	1091	GTC	12;12;12	G;T;C	12;11;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	654	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2313	15.0	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1119	1121	ATA	12;13;13	A;T;A	12;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	654	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2313	15.0	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1227	1229	TCT	16;16;17	T;C;T	16;16;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	654	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2313	15.0	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1614	1616	GCG	19;19;18	G;C;G	18;18;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	654	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2313	15.0	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1827	1829	ATC	20;20;20	A;T;C	20;20;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	398	mdtP	1467	1439	98.05	mdtP.l15.c4.ctg.1	1533	13.3	0	.	p	.	0	S129A	NONSYN	385	387	TCA	479	481	GCG	9;7;6	G;C;G	9;7;6	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	398	mdtP	1467	1439	98.05	mdtP.l15.c4.ctg.1	1533	13.3	0	.	p	.	0	A187T	NONSYN	559	561	GCC	653	655	ACC	9;9;9	A;C;C	9;9;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	398	mdtP	1467	1439	98.05	mdtP.l15.c4.ctg.1	1533	13.3	0	.	p	.	0	H211R	NONSYN	631	633	CAC	725	727	CGC	18;17;17	C;G;C	18;17;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	398	mdtP	1467	1439	98.05	mdtP.l15.c4.ctg.1	1533	13.3	0	.	p	.	0	V250A	NONSYN	748	750	GTT	842	844	GCT	15;15;15	G;C;T	14;15;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	398	mdtP	1467	1439	98.05	mdtP.l15.c4.ctg.1	1533	13.3	0	.	p	.	0	R278K	NONSYN	832	834	AGA	926	928	AAA	10;10;9	A;A;A	10;10;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	398	mdtP	1467	1439	98.05	mdtP.l15.c4.ctg.1	1533	13.3	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	944	946	CGA	6;6;6	C;G;A	6;6;6	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	398	mdtP	1467	1439	98.05	mdtP.l15.c4.ctg.1	1533	13.3	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1109	1111	GCC	10;10;10	G;C;C	10;10;10	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	398	mdtP	1467	1439	98.05	mdtP.l15.c4.ctg.1	1533	13.3	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1121	1123	GAT	13;13;14	G;A;T	13;13;14	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1124	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	3727	15.9	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1427	1429	AAG	10;10;11	A;A;G	10;10;10	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1124	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	3727	15.9	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2504	2506	CTG	14;14;14	C;T;G	14;14;14	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	76	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	180	11.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	666	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2164	16.3	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1040	1042	AAC	12;12;12	A;A;C	12;12;12	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	666	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2164	16.3	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1586	1588	ATA	31;31;32	A;T;A	31;31;31	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	436	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1513	15.1	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1284	1286	GAT	25;25;25	G;A;T	25;25;25	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	436	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1513	15.1	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1287	1289	CTG	25;23;24	C;T;G	25;22;24	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	428	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1408	15.9	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1060	1062	GAG	17;16;16	G;A;G	17;16;16	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	428	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1408	15.9	1	SNP	p	G141D	0	.	.	421	423	GGT	547	549	GGT	25;25;25	G;G;T	25;25;25	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	428	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1408	15.9	1	SNP	p	G141E	0	.	.	421	423	GGT	547	549	GGT	25;25;25	G;G;T	25;25;25	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	428	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1408	15.9	1	SNP	p	R154D	0	.	.	460	462	CGT	586	588	CGT	21;21;20	C;G;T	21;21;20	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	428	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1408	15.9	1	SNP	p	R154A	0	.	.	460	462	CGT	586	588	CGT	21;21;20	C;G;T	21;21;20	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	908	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2672	18.1	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1821	1823	GTG	28;27;27	G;T;G	28;27;27	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	908	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2672	18.1	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1848	1850	TCG	25;25;25	T;C;G,A	25;25;24,1	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	908	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2672	18.1	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2463	2465	AAC	14;14;11	A;A;C	14;14;11	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	908	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2672	18.1	1	SNP	p	A85T	0	.	.	253	255	GCG	477	479	GCG	22;22;22	G,T;C;G	21,1;21;22	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	908	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2672	18.1	1	SNP	p	D111H	0	.	.	331	333	GAT	555	557	GAT	12;12;12	G;A;T	12;12;12	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	908	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2672	18.1	1	SNP	p	S129P	0	.	.	385	387	TCC	609	611	TCC	15;16;16	T;C;C	14;16;16	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	506	parE_1	1893	755	98.41	parE_1.l6.c4.ctg.1	1021	13.7	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	279	281	AAC	15;15;15	A;A;C	15;15;15	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	506	parE_1	1893	755	98.41	parE_1.l6.c4.ctg.1	1021	13.7	1	SNP	p	D476N	0	.	.	1426	1428	GAT	288	290	GAT	16;17;17	G;A;T	15;17;17	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	506	parE_1	1893	913	97.26	parE_1.l6.c4.ctg.2	922	11.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	506	parE_1	1893	147	98.64	parE_1.l6.c4.ctg.3	193	9.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	2754	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1982	73.9	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	901	903	CAG	110;108;113	C;A;G	110;106;111	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	2754	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1982	73.9	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1375	1377	GAT	84;85;85	G;A;T	83;85;85	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1708	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4486	20.3	1	SNP	p	V146F	0	.	.	436	438	GTT	598	600	GTT	18;19;19	G;T;T	18;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1708	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4486	20.3	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1699	1701	CAG	21;21;21	C;A;G	21;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1708	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4486	20.3	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1699	1701	CAG	21;21;21	C;A;G	21;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1708	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4486	20.3	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1738	1740	CAC	22;22;22	C;A;C	22;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1708	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4486	20.3	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1747	1749	CGT	21;19;18	C;G;T	21;19;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1708	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4486	20.3	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1747	1749	CGT	21;19;18	C;G;T	21;19;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1708	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4486	20.3	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1753	1755	TCC	18;19;19	T;C;C	18;19;19	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1708	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4486	20.3	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1759	1761	CTC	17;18;18	C;T;C	17;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1708	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4486	20.3	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1849	1851	ACC	23;23;24	A;C;C	23;23;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1708	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4486	20.3	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1852	1854	CCT	24;22;22	C;C;T	24;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1708	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4486	20.3	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2221	2223	CGT	22;22;22	C;G;T	22;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	0	.	n	.	0	A226G	SNP	226	226	A	428	428	G	125	G,A	124,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	1	SNP	n	A794G	0	.	.	794	794	A	996	996	A	150	A	147	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	1	SNP	n	A794T	0	.	.	794	794	A	996	996	A	150	A	147	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	1	SNP	n	G926C	0	.	.	926	926	G	1128	1128	G	152	G	151	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	1	SNP	n	G926A	0	.	.	926	926	G	1128	1128	G	152	G	151	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	1	SNP	n	G926T	0	.	.	926	926	G	1128	1128	G	152	G	151	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	0	HET	.	.	.	C183T	.	183	183	C	385	385	C	103	C,T	80,21	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	0	HET	.	.	.	T90C	.	90	90	T	292	292	T	105	T,C	81,24	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	0	HET	.	.	.	A250T	.	250	250	A	452	452	A	118	A,T	93,23	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	0	HET	.	.	.	G474A	.	474	474	G	676	676	G	135	G,A	107,28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	0	HET	.	.	.	A253T	.	253	253	A	455	455	A	123	A,T	99,23	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	0	HET	.	.	.	C719T	.	719	719	C	921	921	C	132	C,T	80,52	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	0	HET	.	.	.	A79G	.	79	79	A	281	281	A	109	A,G	77,31	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1203	111.7	0	HET	.	.	.	T273A	.	273	273	T	475	475	T	129	T,A	102,27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	143.0	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	94	A	94	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	143.0	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	94	A	94	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	143.0	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	94	A	94	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	136	100.0	rrsB+.l15.c30.ctg.3	136	34.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.5	139	22.6	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	44	A	44	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.5	139	22.6	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	43	C,G	42,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.5	139	22.6	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	44	C	44	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.5	139	22.6	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	46	G	46	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.5	139	22.6	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	46	G,T	43,2	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	4370	rrsB+	1542	139	95.0	rrsB+.l15.c30.ctg.5	139	22.6	0	.	n	.	0	C1038T	SNP	1038	1038	C	90	90	T	37	T,C	36,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	224	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	711	16.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	212	soxR	465	465	100.0	soxR.l6.c4.ctg.1	801	14.0	1	SNP	p	R20H	0	.	.	58	60	CGC	209	211	CGC	15;15;15	C;G;C	15;15;15	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	212	soxR	465	465	100.0	soxR.l6.c4.ctg.1	801	14.0	1	SNP	p	G121D	0	.	.	361	363	GGT	512	514	GGT	15;15;16	G;G;T	15;15;16	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	144	soxS_1	324	324	99.69	soxS_1.l6.c4.ctg.1	860	8.8	1	SNP	p	A12S	0	.	.	34	36	GCA	276	278	GCA	21;20;20	G;C;A	21;20;20	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	1272	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c17.ctg.1	1405	48.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	1248	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c4.ctg.1	1332	49.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	910	sul2	816	816	100.0	sul2.l6.c30.ctg.1	1321	36.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.;sul2
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	1354	tetA	1200	1200	100.0	tetA.l15.c30.ctg.1	1845	39.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	788	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1166	35.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	566	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1959	15.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
